Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.

Bolino A, Piguet F, Alberizzi V, Pellegatta M, Rivellini C, Guerrero-Valero M, Noseda R, Brombin C, Nonis A, D'Adamo P, et al.